Infectious Diseases: Research and Treatment 2012:5 59-64
Short Report
Published on 19 Nov 2012
DOI: 10.4137/IDRT.S10652
Sign up for email alerts to receive notifications of new articles published in Infectious Diseases: Research and Treatment
The M40 VSV recombinant was engineered to contain overlapping PTAP and PPxY L-domain motifs and flanking residues from the VP40 protein of Ebola virus. Replication of M40 in cell culture is virtually indistinguishable from that of control viruses. However, the presence of the Ebola PTAP motif in the M40 recombinant enabled this virus to interact with and recruit host Tsg101, which was packaged into M40 virions. In this brief report, we compared replication and the pathogenic profiles of M40 and the parental virus M51R in mice to determine whether the presence of the Ebola L-domains and flanking residues altered in vivo characteristics of the virus. Overall, the in vivo characteristics of M40 were similar to those of the parental M51R virus, indicating that the Ebola sequences did not alter pathogenesis of VSV in this small animal model of infection.
PDF (1.20 MB PDF FORMAT)
RIS citation (ENDNOTE, REFERENCE MANAGER, PROCITE, REFWORKS)
BibTex citation (BIBDESK, LATEX)
Since my first enquiry about publishing in Gene Regulation And Systems Biology until the last moment of completing all the steps for publishing my paper, I was always taken seriously as author. All my questions and concerns were answered in a very professional way. The review process was quick and very fair. Reviewers stick to the facts and declare their points of view like a clear thread through the manuscript. I always had an enthusiastic ...
Facebook Google+ Twitter
Pinterest Tumblr YouTube